Aandelen in “Productie van chirurgische apparatuur”

Aandeel	Datum	Koers	Evolutie
CollPlant Biotechnologies Ltd	12/09	2,620 USD -3,32%	-3,32%

Nieuws over “Productie van chirurgische apparatuur”

Toon enkel gratis nieuws

11/09 · Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant · Persbericht

11/09 · Smith+Nephew unveils major clinical evidence and patient access updates for its REGENETEN™ Bioinductive Implant · Persbericht

2/09 · CollPlant to Present at the 2025 International Conference on Biofabrication · Persbericht

5/08 · COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR SECOND QUARTER FINANCIAL RESULTS · Persbericht

14/07 · CollPlant Appoints Collagen Biomaterials Expert as New Head of North America Commercial Operations · Persbericht

7/07 · Smith+Nephew expands market-leading fixation strength of Q-FIX™ All-Suture Anchor portfolio with new knotless option · Persbericht

29/06 · Global Sports Medicine leader Smith+Nephew to sponsor select players competing at Wimbledon, highlighting advanced solutions for joint repair · Persbericht

24/06 · Smith+Nephew’s new TRIGEN™ MAX Tibia Nailing System brings ‘next-level nailing’ to trauma surgeons repairing tibial fractures · Persbericht

23/06 · Ajay Dhankhar joins Smith+Nephew as Chief Corporate Development & Strategy Officer · Persbericht

18/06 · Smith+Nephew and Standard Health partner on first Orthopaedic Ambulatory Surgery Centre in the UK · Persbericht

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe